Response to Frederic Bretzner et al. "Target populations for first-in-human embryonic stem cell research in spinal cord injury".
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 21549322.
- Also identified by DOI 10.1016/j.stem.2011.04.008.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We address concerns raised in this issue by Bretzner et al. (2011) by explaining the rationale for including subjects with subacute, neurologically complete spinal cord injuries in the Phase 1 trial of GRNOPC1. We also present elements of the informed consent process that minimize the likelihood of therapeutic misconception.
Medical subject headings
- Consent Forms
- Patient Selection
- Spinal Cord Injuries